Creating new solutions for sinusitis 

Sinopsys Surgical is dedicated to creating new approaches for the treatment of chronic rhinosinusitis (CRS), commonly known as chronic sinus disease.

Founded by physician-scientists, Sinopsys assembled a team of experienced engineers and clinical researchers to create novel therapies for chronic sinus patients.  Adapting long-standing oculoplastic techniques, the team has developed the Sinopsys Lacrimal Stent (SLS™), which is placed during a novel, reversible and minimally invasive procedure.  This new treatment is intended to significantly reduce CRS symptoms and improve quality of life for patients with CRS. 

Creating new solutions for sinusitis 

Sinopsys Surgical is dedicated to creating new approaches for the treatment of chronic rhinosinusitis (CRS), commonly known as chronic sinus disease.

Founded by physician-scientists, Sinopsys assembled a team of experienced engineers and clinical researchers to create novel therapies for chronic sinus patients.  Adapting long-standing oculoplastic techniques, the team has developed the Sinopsys Lacrimal Stent (SLS™), which is placed during a novel, reversible and minimally invasive procedure.  This new treatment is intended to significantly reduce CRS symptoms and improve quality of life for patients with CRS.